Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **pri-miR-17-92** transcript is a long, polycistronic primary microRNA (pri-miRNA) that serves as the precursor for the miR-17-92 cluster, a group of six processed microRNAs (miR-17, miR-18a, miR-19a, miR-19b-1, miR-20a, and miR-92a-1) encoded within the MIR17HG gene[1][2][4]. After being transcribed, the ~800 nucleotide RNA adopts a distinct tertiary structure that determines how individual miRNA precursors within the transcript are processed into mature microRNAs[1][2][3][4]. These mature miRNAs play crucial roles in regulating cell cycle, proliferation, apoptosis, and development. Dysregulation of the miR-17-92 cluster is linked to cancer, cardiovascular disorders, neurodevelopmental disease, and aging, with overexpression particularly associated with oncogenesis[4][5]. Germline deletions of MIR17HG cause syndromic developmental defects in humans and mice[1]. The primary transcript is regulated at both the transcriptional and post-transcriptional level, including modulation by RNA-binding proteins such as hnRNP A1 and splicing factors such as SRSF3[1][6]. Importantly, **pri-miR-17-92 itself is a non-coding precursor molecule and not a direct therapeutic target; rather, the mature microRNAs derived from it, or the processes regulating its biogenesis, are potential intervention points[5].**
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on miR-17-92 microRNA primary transcript (pri-miR-17-92).